Previous Close | 593.69 |
1-Year Change | 17.4% |
6-Months Change | 8.39% |
3-Months Change | -3.56% |
Moving Avg (50d) | 589.49 |
Moving Avg (200d) | 566.05 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 74.8B |
Beta (3-Years) | 0.29 |
Revenue Growth (ttm) | 14.29% |
Net Profit Margin (ttm) | 0.82% |
Return On Assets (ttm) | 3.98% |
EPS (ttm) | 21.82 |
PE Ratio (ttm) | 27.21 |
Dividend Yield | 0.45% |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Distributors |
Country: | United States |
McKesson Corporation is a publicly-traded American company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United... Wikipedia